Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
52,219
Sort by:
Companion Diagnostics Market Size, Share & Trends Analysis Report By product And service (Assays, Kits, And Reagents, Instruments And Systems, Software And Services), By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Companion Diagnostics Market The global companion diagnostics market size was estimated at USD 9.56 billion in 2025 and is projected to reach USD 20.05 billion by 2033, growing at a CAGR of 10.07% fro...
May 2026
100 pages
